175 related articles for article (PubMed ID: 28767587)
1. Histone deacetylase HDAC1 expression correlates with the progression and prognosis of lung cancer: A meta-analysis.
Cao LL; Song X; Pei L; Liu L; Wang H; Jia M
Medicine (Baltimore); 2017 Aug; 96(31):e7663. PubMed ID: 28767587
[TBL] [Abstract][Full Text] [Related]
2. The expression of histone deacetylase HDAC1 correlates with the progression and prognosis of gastrointestinal malignancy.
Cao LL; Yue Z; Liu L; Pei L; Yin Y; Qin L; Zhao J; Liu H; Wang H; Jia M
Oncotarget; 2017 Jun; 8(24):39241-39253. PubMed ID: 28424407
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinical significance of histone deacetylase 1 expression in breast cancer: A meta-analysis.
Qiao W; Liu H; Liu R; Liu Q; Zhang T; Guo W; Li P; Deng M
Clin Chim Acta; 2018 Aug; 483():209-215. PubMed ID: 29738697
[TBL] [Abstract][Full Text] [Related]
4. Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung.
Minamiya Y; Ono T; Saito H; Takahashi N; Ito M; Mitsui M; Motoyama S; Ogawa J
Lung Cancer; 2011 Nov; 74(2):300-4. PubMed ID: 21466904
[TBL] [Abstract][Full Text] [Related]
5. The natural tumor suppressor protein maspin and potential application in non small cell lung cancer.
Lonardo F; Li X; Kaplun A; Soubani A; Sethi S; Gadgeel S; Sheng S
Curr Pharm Des; 2010 Jun; 16(16):1877-81. PubMed ID: 20337574
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 1 mRNA expression in lung cancer.
Sasaki H; Moriyama S; Nakashima Y; Kobayashi Y; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
Lung Cancer; 2004 Nov; 46(2):171-8. PubMed ID: 15474665
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase-1 as a prognostic factor and mediator of gastric cancer progression by enhancing glycolysis.
Jiang Z; Yang H; Zhang X; Wang Z; Rong R; Wang X
Hum Pathol; 2019 Mar; 85():194-201. PubMed ID: 30500418
[TBL] [Abstract][Full Text] [Related]
8. Role of histone deacetylase expression in intrahepatic cholangiocarcinoma.
Morine Y; Shimada M; Iwahashi S; Utsunomiya T; Imura S; Ikemoto T; Mori H; Hanaoka J; Miyake H
Surgery; 2012 Mar; 151(3):412-9. PubMed ID: 21982637
[TBL] [Abstract][Full Text] [Related]
9. High expression of SNIP1 correlates with poor prognosis in non-small cell lung cancer and SNIP1 interferes with the recruitment of HDAC1 to RB in vitro.
Jeon HS; Choi YY; Fukuoka J; Fujii M; Lyakh LA; Song SH; Travis WD; Park JY; Jen J
Lung Cancer; 2013 Oct; 82(1):24-30. PubMed ID: 23932364
[TBL] [Abstract][Full Text] [Related]
10. HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer.
He J; Shen S; Lu W; Zhou Y; Hou Y; Zhang Y; Jiang Y; Liu H; Shao Y
Oncotarget; 2016 May; 7(22):32754-64. PubMed ID: 27092878
[TBL] [Abstract][Full Text] [Related]
11. Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer.
Zhang X; Tian T; Sun W; Liu C; Fang X
Medicine (Baltimore); 2017 Jun; 96(26):e7346. PubMed ID: 28658153
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
[TBL] [Abstract][Full Text] [Related]
13. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
[TBL] [Abstract][Full Text] [Related]
15. A correlation analysis between HDAC1 over-expression and clinical features of laryngeal squamous cell carcinoma.
Zhao R; Chen K; Cao J; Yu H; Tian L; Liu M
Acta Otolaryngol; 2016; 136(2):172-6. PubMed ID: 26588579
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic Cholangiocarcinoma.
Ohta S; Morine Y; Imura S; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Yamada S; Wada Y; Yamashita S; Bando Y; Shimada M
Anticancer Res; 2019 Nov; 39(11):6025-6033. PubMed ID: 31704828
[TBL] [Abstract][Full Text] [Related]
17. Expression of histone deacetylase 1 and metastasis-associated protein 1 as prognostic factors in colon cancer.
Higashijima J; Kurita N; Miyatani T; Yoshikawa K; Morimoto S; Nishioka M; Iwata T; Shimada M
Oncol Rep; 2011 Aug; 26(2):343-8. PubMed ID: 21617866
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of elevation of vascular endothelial growth factor family expression in patients with non-small cell lung cancer: an updated meta-analysis.
Zheng CL; Qiu C; Shen MX; Qu X; Zhang TH; Zhang JH; Du JJ
Asian Pac J Cancer Prev; 2015; 16(5):1881-95. PubMed ID: 25773840
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Zhu L; Yu H; Liu SY; Xiao XS; Dong WH; Chen YN; Xu W; Zhu T
PLoS One; 2015; 10(4):e0124230. PubMed ID: 25905787
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
